TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

53.87 -0.42 (-0.77%)

Delayed Quote Updated: 10:44 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

February 26, 2025

Via Benzinga

8 Health Care Stocks Whale Activity In Today's Session ↗

January 20, 2025

Via Benzinga

Expert Outlook: TG Therapeutics Through The Eyes Of 5 Analysts ↗

January 15, 2025

Via Benzinga

What's Going On With TG Therapeutics Stock Tuesday? ↗

January 14, 2025

TG Therapeutics Inc (NASDAQ:TGTX) shares are trading higher. The company on Tuesday provided guidance for the fourth quarter and full-year 2024.

Via Benzinga

TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) ↗

November 25, 2024

Via Benzinga

A Closer Look at TG Therapeutics's Options Market Dynamics ↗

November 21, 2024

Via Benzinga

NASDAQ:TGTX stands out as a growth opportunity that won't break the bank. ↗

November 21, 2024

NASDAQ:TGTX is showing decent growth, but is still valued reasonably.

Via Chartmill

The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts ↗

October 29, 2024

Via Benzinga

Delving into NASDAQ:TGTX's Growth Prospects. ↗

October 21, 2024

Why TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock.

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

November 12, 2024

Via Benzinga

Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review ↗

November 08, 2024

A Fed rate cut and a slew of big earnings reports filled out a busy week.

Via Investor's Business Daily

Topics Economy Government

TG Therapeutics Crashes — Reversing A Breakout — On Its Mixed Third-Quarter Results ↗

November 04, 2024

The company raised its sales outlook for the year, though, following stronger-than-expected revenue from its only product.

Via Investor's Business Daily

Why NASDAQ:TGTX qualifies as a high growth stock. ↗

October 15, 2024

Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing?

Via Chartmill

Unlocking the Growth Potential of NASDAQ:TGTX. ↗

September 30, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

Evaluating TG Therapeutics: Insights From 4 Financial Analysts ↗

September 18, 2024

Via Benzinga

What's Going On With TG Therapeutics Stock Wednesday? ↗

September 18, 2024

TG Therapeutics announced it updated its data presentations to include details from the ULTIMATE I & II Phase 3 trials.

Via Benzinga

Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

November 04, 2024

Via Benzinga

Napco Security Technologies Posts Downbeat Results, Joins Centrus Energy, Constellation Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 04, 2024

Via Benzinga

10 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 04, 2024

Via Benzinga

AI Stocks Meta, Oracle Lead Five Names Near Buy Points ↗

November 02, 2024

Two of the 5 top stocks to watch this week tap the artificial intelligence market.

Via Investor's Business Daily

Topics Artificial Intelligence

As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report ↗

November 01, 2024

Amid the election, and a Fed rate vote, earnings season roars ahead.

Via Investor's Business Daily

Topics Economy Stocks

Investors seeking growth at a reasonable cost should explore NASDAQ:TGTX. ↗

October 30, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX) stands out as a growth opportunity that won't break the bank.

Via Chartmill

NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

October 15, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

For those who appreciate growth without the sticker shock, NASDAQ:TGTX is worth considering. ↗

October 09, 2024

NASDAQ:TGTX is showing decent growth, but is still valued reasonably.

Via Chartmill

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 23, 2024

Via Benzinga

Stock Market Hits Record Highs On Big Fed Rate Cut; Apple, Intel, FedEx In Focus: Weekly Review ↗

September 20, 2024

TheApple iPhone 16 went on sale amid mixed signals about demand.

Via Investor's Business Daily

Topics Economy

IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug ↗

September 18, 2024

The company unveiled five-year test results for its multiple sclerosis drug, Briumvi.

Via Investor's Business Daily

Despite its growth, NASDAQ:TGTX remains within the realm of affordability. ↗

September 18, 2024

While growth is established for TG THERAPEUTICS INC (NASDAQ:TGTX), the stock's valuation remains reasonable.

Via Chartmill

NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

September 16, 2024

TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

What's Going On With ADMA Biologics Stock Monday? ↗

September 09, 2024

ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.